Paper21159664
Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma.
Paillas S and 15 others. Cancer Res, 2011. Cited by 79 papers, by iCite.
Cite this record
ConductScience Library. Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma. Papers, record 21159664. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21159664
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Camptothecin | Major topic |
| Colonic Neoplasms | Major topic |
| Protein Kinase Inhibitors | Major topic |
| p38 Mitogen-Activated Protein Kinases | Major topic |
| Animals | |
| Drug Resistance, Neoplasm | |
| Drug Synergism | |
| Female | |
| Fluorouracil | |
| HCT116 Cells | |
| Humans | |
| Imidazoles | |
| Immunohistochemistry | |
| Irinotecan | |
| Isoenzymes | |
| Leucovorin | |
| MAP Kinase Signaling System | |
| Mice | |
| Mice, Nude | |
| Phosphorylation | |
| Pyridines | |
| Xenograft Model Antitumor Assays |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9649129 | Determinants of CPT-11 and SN-38 activities in human lung cancer cells. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9649129 | PubMed |
| 2 | 19578043 | (-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells. | Carcinogenesis | 2009 | https://conductscience.org/library/papers/19578043 | PubMed |
| 3 | 16618717 | KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. | Cancer Res | 2006 | https://conductscience.org/library/papers/16618717 | PubMed |
| 4 | 12453851 | Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity. | Ann Oncol | 2002 | https://conductscience.org/library/papers/12453851 | PubMed |
| 5 | 19608275 | Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition. | Leuk Res | 2010 | https://conductscience.org/library/papers/19608275 | PubMed |
| 6 | 17496916 | Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. | Oncogene | 2007 | https://conductscience.org/library/papers/17496916 | PubMed |
| 7 | 15686620 | Activation and signaling of the p38 MAP kinase pathway. | Cell Res | 2005 | https://conductscience.org/library/papers/15686620 | PubMed |
| 8 | 12650604 | MKK4 and metastasis suppression: a marriage of signal transduction and metastasis research. | Clin Exp Metastasis | 2003 | https://conductscience.org/library/papers/12650604 | PubMed |
| 9 | 11809696 | X-ray repair cross-complementing gene I protein plays an important role in camptothecin resistance. | Cancer Res | 2002 | https://conductscience.org/library/papers/11809696 | PubMed |
| 10 | 19564926 | Nuclear localization of p38 MAPK in response to DNA damage. | Int J Biol Sci | 2009 | https://conductscience.org/library/papers/19564926 | PubMed |
| 11 | 16990856 | Topoisomerase I inhibitors: camptothecins and beyond. | Nat Rev Cancer | 2006 | https://conductscience.org/library/papers/16990856 | PubMed |
| 12 | 18772225 | A single mutation in the 729 residue modulates human DNA topoisomerase IB DNA binding and drug resistance. | Nucleic Acids Res | 2008 | https://conductscience.org/library/papers/18772225 | PubMed |
| 13 | 2170010 | Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody. | Cancer Res | 1990 | https://conductscience.org/library/papers/2170010 | PubMed |
| 14 | 16546964 | Novel missense mutation of the DNA topoisomerase I gene in SN-38-resistant DLD-1 cells. | Mol Cancer Ther | 2006 | https://conductscience.org/library/papers/16546964 | PubMed |
| 15 | 19630571 | Evolving treatment of advanced colon cancer. | Annu Rev Med | 2009 | https://conductscience.org/library/papers/19630571 | PubMed |
| 16 | 8910361 | Crystal structure of p38 mitogen-activated protein kinase. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8910361 | PubMed |
| 17 | 8275492 | Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. | Cancer Res | 1994 | https://conductscience.org/library/papers/8275492 | PubMed |
| 18 | 15027118 | ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases. | Int J Cancer | 2004 | https://conductscience.org/library/papers/15027118 | PubMed |
| 19 | 1338578 | Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content. | Oncol Res | 1992 | https://conductscience.org/library/papers/1338578 | PubMed |
| 20 | 16785992 | Cisplatin induces PKB/Akt activation and p38(MAPK) phosphorylation of the EGF receptor. | Oncogene | 2006 | https://conductscience.org/library/papers/16785992 | PubMed |
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41595212 | Conversational AI-Enabled Precision Oncology Reveals Context-Dependent MAPK Pathway Alterations in Hispanic/Latino and Non-Hispanic White Colorectal Cancer Stratified by Age and FOLFOX Exposure. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41595212 | PubMed |
| 41312772 | Maritoclax Overcomes FBW7 Deficiency-Driven Irinotecan Resistance in Colorectal Cancer by Targeting MCL1. | Cancer Med | 2025 | https://conductscience.org/library/papers/41312772 | PubMed |
| 41289737 | miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response. | Pharmacol Rev | 2026 | https://conductscience.org/library/papers/41289737 | PubMed |
| 40867564 | Dormancy in Colorectal Carcinoma: Detection and Therapeutic Potential. | Biomolecules | 2025 | https://conductscience.org/library/papers/40867564 | PubMed |
| 39061915 | Anthocyanin-Rich Berry Extracts Affect SN-38-Induced Response: A Comparison of Non-Tumorigenic HCEC-1CT and HCT116 Colon Carcinoma Cells. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39061915 | PubMed |
| 38482210 | Expression and prognosis of ADAMTS18 in different tumors. | Front Oncol | 2024 | https://conductscience.org/library/papers/38482210 | PubMed |
| 38067418 | In Vitro Inhibitory Potential of Different Anthocyanin-Rich Berry Extracts in Murine CT26 Colon Cancer Cells. | Molecules | 2023 | https://conductscience.org/library/papers/38067418 | PubMed |
| 37740222 | Small molecule targeting of the p38/Mk2 stress signaling pathways to improve cancer treatment. | BMC Cancer | 2023 | https://conductscience.org/library/papers/37740222 | PubMed |
| 37041570 | Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells. | Cell Biosci | 2023 | https://conductscience.org/library/papers/37041570 | PubMed |
| 36105464 | Multi-stage virtual screening of natural products against p38α mitogen-activated protein kinase: predictive modeling by machine learning, docking study and molecular dynamics simulation. | Heliyon | 2022 | https://conductscience.org/library/papers/36105464 | PubMed |
| 36051345 | Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide. | World J Gastroenterol | 2022 | https://conductscience.org/library/papers/36051345 | PubMed |
| 35834097 | AKT inhibition sensitizes EVI1 expressing colon cancer cells to irinotecan therapy by regulating the Akt/mTOR axis. | Cell Oncol (Dordr) | 2022 | https://conductscience.org/library/papers/35834097 | PubMed |
| 35501462 | Role of p38 MAP kinase in cancer stem cells and metastasis. | Oncogene | 2022 | https://conductscience.org/library/papers/35501462 | PubMed |
| 35163030 | Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35163030 | PubMed |
| 35008796 | The p38 MAPK Components and Modulators as Biomarkers and Molecular Targets in Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/35008796 | PubMed |
| 34596797 | Atypical activation of signaling downstream of inactivated Bcr-Abl mediates chemoresistance in chronic myeloid leukemia. | J Cell Commun Signal | 2022 | https://conductscience.org/library/papers/34596797 | PubMed |
| 34552614 | Predicting the Survival and Immune Landscape of Colorectal Cancer Patients Using an Immune-Related lncRNA Pair Model. | Front Genet | 2021 | https://conductscience.org/library/papers/34552614 | PubMed |
| 34497429 | Stress-activated kinases as therapeutic targets in pancreatic cancer. | World J Gastroenterol | 2021 | https://conductscience.org/library/papers/34497429 | PubMed |
| 33255177 | CDK4/6 and MAPK-Crosstalk as Opportunity for Cancer Treatment. | Pharmaceuticals (Basel) | 2020 | https://conductscience.org/library/papers/33255177 | PubMed |
| 32901874 | Anti‑proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF‑β1/p53 signaling pathway. | Oncol Rep | 2020 | https://conductscience.org/library/papers/32901874 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MAPK11 | 5600 | PubTator's text mining | https://conductscience.org/library/genes/5600 | NCBI Gene |
| MAPK14 | 1432 | PubTator's text mining | https://conductscience.org/library/genes/1432 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21159664
GET https://conductscience.org/api/papers/v1/21159664/references?page=2